Madurai News

Gastrointestinal Stromal Tumor (GIST) Market Trends, Growth Opportunities and Challenges, Clinical Development Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast

 Breaking News
  • No posts were found

Gastrointestinal Stromal Tumor (GIST) Market Trends, Growth Opportunities and Challenges, Clinical Development Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast

August 11
04:33 2021
Gastrointestinal Stromal Tumor (GIST) Market Trends, Growth Opportunities and Challenges, Clinical Development Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast
Delveinsight Business Research LLP

DelveInsight’s “Gastrointestinal Stromal Tumor (GIST) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Gastrointestinal Stromal Tumor (GIST) Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Gastrointestinal Stromal Tumor (GIST) Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Gastrointestinal Stromal Tumor (GIST) market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Gastrointestinal Stromal Tumor (GIST) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

Gastrointestinal Stromal Tumor (GIST) Market

A gastrointestinal stromal tumor (GIST) is rare cancer affecting the digestive tract or nearby structures within the abdomen. It is a sarcoma that arises either from cells called interstitial cells of cajal (ICCs) or from less differentiated stem cells or precursor cells that can develop into ICCs. Because GIST cancers arise from the GI tract wall, they are usually attached to the outside of the involved organ, growing outward; this is sometimes referred to as exophytic. Occasionally a GIST may grow inward through the muscle layer of the GI tract wall and then develop partly inside the digestive tract lumen; this is sometimes called endophytic.

Gastrointestinal Stromal Tumor (GIST) Market Key Facts

  • As per DelveInsight, the total incident cases of Gastrointestinal Stromal Tumor (GIST) in the US were observed to be 5,090 in 2017.

  • The stages of Gastrointestinal Stromal Tumor (GIST) are classified into three categories, i.e., localized, regional, distant, and unknown. As per DelveInsight’s estimates, the localized cases account for approximately 60% of the total cases.

  • According to Ma et al. (2015), Gastrointestinal Stromal Tumor (GIST) is more common in males than females with a rate ratio of 1.35.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/gastrointestinal-stromal-tumor-gist-market

Key Benefits of Gastrointestinal Stromal Tumor (GIST) Market Report

  • The market report provides an in-depth analysis of Gastrointestinal Stromal Tumor (GIST) Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

  • The report will help in developing business strategies by understanding the Gastrointestinal Stromal Tumor (GIST) Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

  • The market report covers the Gastrointestinal Stromal Tumor (GIST) current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

  • The report provides a detailed assessment of the Gastrointestinal Stromal Tumor (GIST) market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Gastrointestinal Stromal Tumor (GIST) Market 

The market size of Gastrointestinal Stromal Tumor is expected to increase during the forecast period owing to the increasing prevalent population of Gastrointestinal Stromal Tumor (GIST) patients along with rising in awareness and disease understanding

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Gastrointestinal Stromal Tumor (GIST) market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Gastrointestinal Stromal Tumor (GIST) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request for Sample @ Gastrointestinal Stromal Tumor (GIST) Therapeutics Market Assessment

Gastrointestinal Stromal Tumor (GIST) Epidemiology

The epidemiology section covers insights about the historical and current Gastrointestinal Stromal Tumor (GIST) patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Gastrointestinal Stromal Tumor (GIST) Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastrointestinal Stromal Tumor (GIST) market or expected to get launched in the market during the study period. The analysis covers Gastrointestinal Stromal Tumor (GIST) market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Gastrointestinal Stromal Tumor (GIST) Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Some of the key players in the Gastrointestinal Stromal Tumor (GIST) market include:

  • Advenchen Laboratories

  • Deciphera Pharmaceuticals

  • Pfizer

  • Bayer

  • Blueprint Medicines Corporation

  • Novartis

  • Arog Pharmaceuticals

  • Taiho Oncology

And others.

Gastrointestinal Stromal Tumor (GIST) Therapies covered in the report include:

  • AL3818

  • Ripretinib

  • TAS-116

  • Crenolanib

  • Avapritinib

  • Gleevec

  • Vitrakvi

  • Stivarga

And many others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Gastrointestinal Stromal Tumor (GIST) Competitive Intelligence Analysis

4. Gastrointestinal Stromal Tumor (GIST) Market Overview at a Glance

5. Gastrointestinal Stromal Tumor (GIST) Disease Background and Overview

6. Gastrointestinal Stromal Tumor (GIST) Patient Journey

7. Gastrointestinal Stromal Tumor (GIST) Epidemiology and Patient Population

8. Gastrointestinal Stromal Tumor (GIST) Treatment Algorithm, Current Treatment, and Medical Practices

9. Gastrointestinal Stromal Tumor (GIST) Unmet Needs

10. Key Endpoints of Gastrointestinal Stromal Tumor (GIST) Treatment

11. Gastrointestinal Stromal Tumor (GIST) Marketed Products

12. Gastrointestinal Stromal Tumor (GIST) Emerging Therapies

13. Gastrointestinal Stromal Tumor (GIST) Seven Major Market Analysis

14. Attribute Analysis

15. Gastrointestinal Stromal Tumor (GIST) Market Outlook (7 major markets)

16. Gastrointestinal Stromal Tumor (GIST) Access and Reimbursement Overview

17. KOL Views on the Gastrointestinal Stromal Tumor (GIST) Market.

18. Gastrointestinal Stromal Tumor (GIST) Market Drivers

19. Gastrointestinal Stromal Tumor (GIST) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/gastrointestinal-stromal-tumor-gist-market

Latest Reports By DelveInsight

Gastrointestinal Stromal Tumor (GIST) Pipeline Insights

Gastrointestinal Stromal Tumor (GIST) Pipeline Insight, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Gastrointestinal Stromal Tumor (GIST) market.

Dementia with Diabetes Market

DelveInsight’s “Dementia with Diabetes Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dementia with Diabetes market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/